MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $223,566 | -30.8% | 13,938 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $323,083 | +1.5% | 13,938 | +1.7% | 0.00% | -50.0% |
Q1 2023 | $318,460 | +100.9% | 13,709 | +25.5% | 0.00% | +100.0% |
Q4 2022 | $158,507 | -23.4% | 10,924 | +0.7% | 0.00% | 0.0% |
Q3 2022 | $207,000 | +5.1% | 10,846 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $197,000 | -27.8% | 10,846 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $273,000 | -26.2% | 10,846 | -19.0% | 0.00% | -50.0% |
Q4 2021 | $370,000 | -2.4% | 13,398 | +14.2% | 0.00% | 0.0% |
Q3 2021 | $379,000 | +6.5% | 11,736 | +0.7% | 0.00% | 0.0% |
Q2 2021 | $356,000 | +1.4% | 11,654 | +1.2% | 0.00% | 0.0% |
Q1 2021 | $351,000 | +99.4% | 11,513 | +29.7% | 0.00% | +100.0% |
Q4 2020 | $176,000 | +104.7% | 8,877 | +33.9% | 0.00% | 0.0% |
Q3 2020 | $86,000 | +14.7% | 6,631 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $75,000 | -1.3% | 6,631 | +25.0% | 0.00% | 0.0% |
Q1 2020 | $76,000 | -37.2% | 5,305 | +18.9% | 0.00% | 0.0% |
Q4 2019 | $121,000 | -5.5% | 4,461 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $128,000 | +3.2% | 4,461 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $124,000 | -6.8% | 4,461 | +11.7% | 0.00% | 0.0% |
Q1 2019 | $133,000 | -10.7% | 3,994 | -22.3% | 0.00% | 0.0% |
Q4 2018 | $149,000 | -27.7% | 5,137 | +14.7% | 0.00% | -50.0% |
Q3 2018 | $206,000 | +23.4% | 4,477 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $167,000 | +57.5% | 4,477 | +24.9% | 0.00% | 0.0% |
Q1 2018 | $106,000 | -13.8% | 3,584 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $123,000 | +6.0% | 3,584 | +11.3% | 0.00% | 0.0% |
Q3 2017 | $116,000 | +39.8% | 3,220 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $83,000 | +72.9% | 3,220 | +30.2% | 0.00% | – |
Q1 2017 | $48,000 | +17.1% | 2,474 | 0.0% | 0.00% | – |
Q4 2016 | $41,000 | -19.6% | 2,474 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $51,000 | -23.9% | 2,474 | +13.7% | 0.00% | 0.0% |
Q2 2016 | $67,000 | -17.3% | 2,175 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $81,000 | -13.8% | 2,175 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $94,000 | +248.1% | 2,175 | +202.5% | 0.00% | – |
Q3 2015 | $27,000 | +200.0% | 719 | +162.4% | 0.00% | – |
Q2 2015 | $9,000 | -10.0% | 274 | 0.0% | 0.00% | – |
Q1 2015 | $10,000 | -99.3% | 274 | -99.3% | 0.00% | -100.0% |
Q2 2014 | $1,440,000 | -31.4% | 37,000 | -63.0% | 0.04% | -39.1% |
Q4 2013 | $2,098,000 | -10.7% | 100,000 | 0.0% | 0.07% | -14.8% |
Q3 2013 | $2,350,000 | +191.6% | 100,000 | +233.3% | 0.08% | +189.3% |
Q2 2013 | $806,000 | -62.7% | 30,000 | -64.7% | 0.03% | -63.2% |
Q1 2013 | $2,159,000 | +126.3% | 85,000 | +142.9% | 0.08% | +100.0% |
Q4 2012 | $954,000 | -35.7% | 35,000 | -36.4% | 0.04% | -36.7% |
Q3 2012 | $1,484,000 | -23.9% | 55,000 | -32.9% | 0.06% | -31.0% |
Q2 2012 | $1,949,000 | – | 82,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |